HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer.
Autor: | M. G., Archana, K. S., Anusree, B. S., Unnikrishnan, P. L., Reshma, H. P., Syama, J., Sreekutty, Joseph, Manu M., T. T., Sreelekha |
---|---|
Zdroj: | ACS Applied Materials & Interfaces; 5/22/2024, Vol. 16 Issue 20, p25710-25726, 17p |
Databáze: | Supplemental Index |
Externí odkaz: |